Trial intelligence / Profile preview

Transvaginal metronidazole after cystectomy for endometriomas

jRCTs041210114Completed

Start
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of metronidazole in endometrioma. Primary endpoint: Recurrence rate of ovarian endometriotic cysts. Started Feb 2022; status: completed.

02

Drugs

metronidazole
03

Conditions

endometrioma

Beyond the preview

Go deeper on jRCTs041210114.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041210114.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call